Midatech Pharma plc Total Liabilities 2011-2026 | MTP

Annual Total Liabilities Midatech Pharma plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
6.46 M	5.86 M	2.36 M	2.46 M	3.1 M	11.3 M	3.52 M	14.5 M	11 M	17.2 M	7.14 M	4.41 M	-	-

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
17.2 M	2.36 M	7.44 M

Quarterly Total Liabilities Midatech Pharma plc

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	2.46 M	-	-	-	3.1 M	-	-	-	11.3 M	-	-	-	3.52 M	-	-	-	14.5 M	-	-	-	11 M	-	-	-	17.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in GBP currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
17.2 M	2.46 M	9.01 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Alector ALEC	263 M	$ 2.19	-9.77 %	$ 226 M	USA
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Cabaletta Bio CABA	17.5 M	$ 3.34	0.45 %	$ 3.9 M	USA
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	6.61 M	-	-10.17 %	$ 12.2 K	USA
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Codexis CDXS	82.1 M	$ 1.02	1.49 %	$ 74.9 M	USA
AbCellera Biologics ABCL	390 M	$ 3.74	3.6 %	$ 1.12 B	Canada
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
Cerus Corporation CERS	144 M	$ 2.6	1.37 %	$ 480 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Cellectis S.A. CLLS	253 M	$ 3.87	-0.39 %	$ 116 M	France
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
CNS Pharmaceuticals CNSP	2.52 M	$ 3.23	2.22 %	$ 1.23 M	USA
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
AIkido Pharma AIKI	7.27 M	-	1.93 %	$ 17.4 M	USA
Collegium Pharmaceutical COLL	1.36 B	$ 41.75	0.19 %	$ 1.32 B	USA
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
Corcept Therapeutics Incorporated CORT	189 M	$ 36.14	1.23 %	$ 3.75 B	USA
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA
Amarin Corporation plc AMRN	280 M	$ 13.98	1.27 %	$ 5.7 B	Irlanda
Aileron Therapeutics ALRN	7.8 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	5.24 M	-	4.14 %	$ 49.1 M	USA
Catalyst Pharmaceuticals CPRX	150 M	$ 23.77	2.99 %	$ 2.91 B	USA
Alpine Immune Sciences ALPN	107 M	-	-	$ 2.17 B	USA
Corbus Pharmaceuticals Holdings CRBP	35.2 M	$ 8.41	-1.87 %	$ 36.4 M	USA
Cardiff Oncology CRDF	16.5 M	$ 1.94	0.01 %	$ 130 M	USA
Curis CRIS	47.3 M	$ 1.1	-3.51 %	$ 6.94 M	USA
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
CorMedix CRMD	11.9 M	$ 7.16	0.42 %	$ 364 M	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
Champions Oncology CSBR	28.6 M	$ 6.14	3.89 %	$ 83.9 M	USA
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	14.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Citius Pharmaceuticals CTXR	42.5 M	$ 0.72	-2.34 %	$ 4.84 M	USA
Athira Pharma ATHA	13.9 M	-	-	$ 269 M	USA
Aridis Pharmaceuticals ARDS	38.9 M	-	17.91 %	$ 11.1 M	USA
Altimmune ALT	15.8 M	$ 4.21	-2.32 %	$ 299 M	USA
CEL-SCI Corporation CVM	14.1 M	$ 3.88	-8.92 %	$ 247 M	USA